G. Fontana et al., Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: Influence of PEG coating on the particle size, drug release rate and phagocytic uptake, BIOMATERIAL, 22(21), 2001, pp. 2857-2865
Polyethyleneglycol (PEG)-coated polyethylcyanoacrylate (PECA) nanoparticles
loaded with amoxicillin were prepared and the influence of the PEG coating
on the particle size, zeta potential, drug release rate and phagocytic upt
ake by murine macrophages was studied. Experimental results show that this
colloidal drug delivery system could be useful for intravenous or oral admi
nistration. The profile of amoxicillin release from PECA nanoparticles syst
em was studied under various conditions similar to those of some corporeal
fluids. In all these experiments, amoxicillin release in the free form was
studied by HPLC analysis. Experimental results showed that at pH 7.4 drug r
elease rises when molecular weight of PEG added to polymerization medium in
creases; in human plasma on the contrary drug release is reduced as molecul
ar weight of PEG rises. Phagocytosis was evaluated by incubating amoxicilli
n-loaded PECA nanoparticles with murine macrophages and determining the amo
unt of phagocytized nanoparticles by dosing the amoxicillin present inside
the macrophages. The results of this study showed significative differences
between nanoparticles prepared in the presence or in the absence of PEG an
d demonstrated that the PEG coating reduces the macrophages uptake. These r
esults suggest that nanoparticles prepared in the presence of PEG are steal
th carriers, which could be an injectable colloidal system able to avoid MP
S recognition after intravenous injection. Experimental data of drug releas
e at pH 1.1 and in the presence of urease, taking into account the mucoadhe
sive properties of polyalkylcyanoacrylate nanoparticles and the activity of
the amoxicillin versus Helicobacter pylori, suggest moreover that the coll
oidal drug delivery system obtained in our laboratory could be useful for t
he treatment of diseases caused by H. pylori by peroral administration. (C)
2001 Elsevier Science Ltd. All rights reserved.